Suzhou, China

Xin Yu

This inventor holds 1 USPTO granted patent. Top assignee: Life Technologies Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Yu. Retrieved from https://idiyas.com/inventor/xin-yu-yra5zri4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Xin Yu

Introduction

Xin Yu is a notable inventor based in Suzhou, China. He has made significant contributions to the field of lentiviral vector production. His innovative approach has led to the development of a serum-free suspension system that enhances the efficiency of lentiviral production.

Latest Patents

Xin Yu holds a patent for a serum-free suspension system for lentiviral production. This system includes a lentiviral culture supplement to control cell growth, a transfection reagent comprising DHDMS, DOPE, and cholesterol to increase transfection efficiency, and a lentiviral production enhancer made up of sodium propionate, sodium butyrate, and caffeine. The system is designed to operate without serum, which is a significant advancement in the field. The methods outlined in his patent involve culturing eukaryotic cells in a serum-free medium and utilizing the lentiviral culture supplement and transfection reagents to boost production.

Career Highlights

Xin Yu is currently employed at Life Technologies Corporation, where he continues to innovate in the field of biotechnology. His work focuses on improving the efficiency and effectiveness of viral vector production systems.

Collaborations

Xin collaborates with Xavier De Mollerat Du Jeu, who is also a key figure in his research endeavors.

Conclusion

Xin Yu's contributions to lentiviral vector production through his innovative patent demonstrate his commitment to advancing biotechnology. His work is paving the way for more efficient production methods in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…